Applied Health Economics and Health Policy

Article	Citations
Cost-Effectiveness and Value of Information Analyses of Caplacizumab for the Treatment of Thrombotic Thrombocytopenic Purpura in Brazil	192
Cost-Effectiveness of a Universal School-Based Mental Health Prevention Program: An Economic Modeling Study in a Limited Income Context	100
Therapy, Pills and Unmet Needs for Financial Reasons: Socioeconomic Inequalities and Inequities in Access to Mental Health Care in Spain 2014–2020	51
Cost-Effectiveness Analysis of Evolocumab or Inclisiran in Combination with Statins Versus Statin Monotherapy Among Patients with ASCVD in China	42
Partnerships in Public Health Economics: Reflective Lessons from UK Obesity Research	38
Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual Framework	33
Improving Consumer Engagement in Health Technology Assessment and Decision Making: Lessons from ‘Values in Science’	32
Assessing the Direct Impact of Death on Discrete Choice Experiment Utilities	29
Cost-Effectiveness of Perinatal Depression Screening: A Scoping Review	28
Cost-Effective and Sustainable Drug Use in Hospitals: A Systematic and Practice-Based Approach	28
Which Factors are Holding up the Integration of the Environmental Impact of Health Technologies in Health Technology Assessment? Insights from a Multi-Stakeholder Interview Study	26
Exploratory Approach to Incorporating Carbon Footprint in Health Technology Assessment (HTA) Modelling: Cost-Effectiveness Analysis of Health Interventions in the United Kingdom	25
Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines	25
A Guideline-Implementation Intervention to Improve the Management of Low Back Pain in Primary Care: A Difference-in-Difference-in-Differences Analysis	22
Economic Evaluation of Evusheld for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand	18
Selection and Prioritization of Medical Devices for HTA Evaluation: A Systematic Review of Existing Approaches	18
Psychometric Evaluation of the PedsQL GCS and CHU9D in Australian Children and Adolescents with Common Chronic Health Conditions	17
Financing Comprehensive Immunization Services in Lao PDR: A Fiscal Space Analysis From a Public Policy Perspective	17
The Economics of Antibiotic Resistance: A Systematic Review and Meta-analysis Based on Global Research	17
Local Level Economic Evaluation: What is it? What is its Value? Is it Sustainable?	16
10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?	16
Economic Evaluation Evidence for Resource-Allocation Decision Making: Bridging the Gap for Local Decision Makers Using English Case Studies	16
The Economic Cost of Rising Non-communicable Diseases in India: A Systematic Literature Review of Methods and Estimates	15
Correction to: Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis	15
Acknowledgement to Reviewers	15

How is Value Defined in Molecular Testing in Cancer? A Scoping Review	14
A Cost–Utility Analysis of Surgical Site Infection Prevention: Broadening the Scope	14
A Systematic Review of the World’s Largest Government Sponsored Health Insurance Scheme for 500 Million Beneficiaries in India: Pradhan Mantri Jan Arogya Yojana	14
Including Pharmaceuticals in Bundled Payments	14
Politicised Changes to the NICE Threshold Risk Making Cost-Effectiveness Analysis Performative, Not Informative	14
How Much Should be Invested in Lung Care Across the WHO European Region? Applying a Monetary Value to Disability-Adjusted Life-Years Within the International Respiratory Coalition’s Lung Facts	13
Development of a Health Technology Assessment Quality Appraisal Checklist (HTA-QAC) for India	13
Economic Effects of Fixed-Dose Versus Loose-Dose Combination Therapy for Type 2 Diabetes Patients	13
Estimating the Health Effects of Expansions in Health Expenditure in Indonesia: A Dynamic Panel Data Approach	13
Quality-Adjusted Life Expectancy and Cost-Effectiveness Thresholds in Three High-Income Regions in Asia	13
Correction: Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?	13
The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes	13
Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon	12
Social Costs of Smoking in the Czech Republic	12
Economic Evaluation of Bruton’s Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukaemia in South Africa	12
Contextual Factors that Influence Antibiotic Prescribing: A Discrete Choice Experiment of GP Registrars	12
Measures of Performance and Clinical Superiority Thresholds for ‘Test-and-treat’ Predictive Biomarkers	11
Cost-Effectiveness and Budget Impact Analysis of Implementing a 'Soft Opt-Out' System for Kidney Donation in Australia	11
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy	11
A Systematic Review of Cost-Effectiveness Analyses of Colorectal Cancer Screening in Europe: Have Studies Included Optimal Screening Intensities?	11
Correction to: Different Frameworks, Similar Results? Head-to-Head Comparison of the Generic Preference-Based Health-Outcome Measures CS-Base and EQ-5D-5L	11
Is Economic Evaluation and Care Commissioning Focused on Achieving the Same Outcomes? Resource-Allocation Considerations and Challenges Using England as a Case Study	10
Cost-Effectiveness of Anti-retroviral Adherence Interventions for People Living with HIV: A Systematic Review of Decision Analytical Models	10
Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–2040	10
Young People’s Preferences for Web-Based Mental Health Interventions for Managing Anxiety and Depression: A Discrete Choice Experiment	10
Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges	10
Sedaconda ACD-S for Sedation with Volatile Anaesthetics in Intensive Care: A NICE Medical Technologies Guidance	10
Guiding Health Resource Allocation: Using Population Net Health Benefit to Align Disease Burden with Cost Effectiveness for Informed Decision Making	10
Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland	10
Machine Learning-Assisted Health Economics and Policy Reviews: A Comparative Assessment	10
Trump’s Drug Pricing Order and the Domestic Economic Trade-Off	10
The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework	9
Mechanisms Considering Public Investment in Pricing and Reimbursement Decisions of Medicines and Other Health Technologies: A Scoping Review	9
Societal Cost of Racial Pneumococcal Disease Disparities in US Adults Aged 50 Years or Older	9
Information Asymmetry in Hospitals: Evidence of the Lack of Cost Awareness in Clinicians	9
The Health Economics of Genomic Technologies: A Growing Evidence Base on Value	9
Measurement of Catastrophic Health Expenditure in India: A Systematic Review and Meta-Analysis	9
A Systematic Review of Economic Evaluations on Interventions Targeting Insomnia or Hypersomnia	8
The Limitations and Potentials of Evaluating Economic Aspects of Community-Based Health Promotion: A Critical Review	8
Comparing Preferences for Disease Profiles: A Discrete Choice Experiment from a US Societal Perspective	8
Analysing the Efficiency of Health Systems: A Systematic Review of the Literature	8
Headroom Analysis for Early Economic Evaluation: A Systematic Review	8
Productivity Loss and Indirect Costs for Patients Newly Diagnosed with Early- versus Late-Stage Cancer in the USA: A Large-Scale Observational Research Study	8
A Head-On Comparison of EQ-VT- and Crosswalk-Based EQ-5D-5L Value Sets	8
Discrete Event Simulation in R using the ‘Simmer’ Package for Health Economic Modelling: A Tutorial and Illustration in Colon Cancer	7
A Systematic Review of Health Economic Evaluations and Budget Impact Analyses to Inform Healthcare Decision-Making in Central America	7
EQ-5D-5L Population Norms for Italy	7
Using Genomic Heterogeneity to Inform Therapeutic Decisions for Metastatic Colorectal Cancer: An Application of the Value of Heterogeneity Framework	7
Estimating a Drug’s Price After Loss of Exclusivity as a Function of Its Cost of Goods Sold	7
Ensuring Epidemiological Consistency in Risk-Stratified Cancer Screening Models: A Novel Approach Based on Flemish Breast Cancer Screening	7

Estimated Carbon Savings from Changing Surgical Trends in Primary Elective Total Hip Arthroplasty in England: A Retrospective Observational Study	7
Exploring Consumer Preferences for Cannabis Vaping Products to Support Public Health Policy: A Discrete Choice Experiment	6
Health Reform in Aotearoa New Zealand: Insights on Health Equity Challenges One Year On	6
Structured Expert Elicitation to Inform Long-Term Survival Extrapolations in Advanced Renal Cell Carcinoma	6
Utilising Health Technology Assessment to Develop Managed Access Protocols to Facilitate Drug Reimbursement in Ireland	6
Review and Assessment of Policy Options for Improving Access to Combination Therapies in Oncology in Europe	6
Correction: Economic Evaluations of Robotic-Assisted Surgery: Methods, Challenges and Opportunities	6
Modelled Distributional Cost-Effectiveness Analysis of Childhood Obesity Interventions: A Demonstration	6
The Impact of Value-Based Payment Models for Networks of Care and Transmural Care: A Systematic Literature Review	6
Preferences for Digital Mental Health Services in Urban China: A Discrete Choice Experiment	6
Discrete Choice Experiments in Health State Valuation: A Systematic Review of Progress and New Trends	6
New Horizons? Assessing General Public Preferences for a Wellbeing Economy in the Post-COVID-19 World	6
Cost-Utility Analysis of TNF-α Inhibitors, B Cell Inhibitors, and JAK Inhibitors Versus csDMARDs for Rheumatoid Arthritis Treatment	6
Genetic Test Utilization and Cost among Families of Children Evaluated for Genetic Conditions: An Analysis of USA Commercial Claims Data	6
Costs and Budget Impact of a Health System Strengthening Intervention for Hypertension and Cardiovascular Disease Care in Ghana	6
Use of Decision-Analytic Modelling to Assess the Cost-Effectiveness of Diagnostic Imaging of the Spine, Shoulder, and Knee: A Scoping Review	6
Model-Based Economic Evaluations of Interventions for Dementia: An Updated Systematic Review and Quality Assessment	6
The Role of Price Variation in Economic Analyses for Cancer Screenings: A Rapid Review	6
Cost-Effectiveness and Value of Information Analysis of an Ambient Intelligent Geriatric Management (AmbIGeM) System Compared to Usual Care to Prevent Falls in Older People in Hospitals	6
Using Economics to Impact Local Obesity Policy: Introducing the UK Centre for Economics of Obesity (CEO)	6
Economic Evaluations of Preventive Interventions for Dental Caries and Periodontitis: A Systematic Review	5
Productivity Losses due to Health Problems Arising from COVID-19 Pandemic: A Systematic Review of Population-Level Studies Worldwide	5
The Value of New: Consideration of Product Novelty in Health Technology Assessments of Pharmaceuticals	5
Quality-Adjusted Life Expectancy Norms Based on the EQ-5D-5L and SF-6Dv2 for China	5
The Impact of Alteplase Coverage on Health Equity for the Treatment of Ischemic Stroke in the USA: A Distributional Cost-Effectiveness Analysis	5
Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in Australia	5
Comparison of the Measurement Properties of EQ-5D-5L and SF-6Dv2 in COVID-19 Patients in China	5
Cost-Effectiveness and Public Health Impact of Newborn Screening for Spinal Muscular Atrophy in France	5
A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany	5
Economic Epidemiology: A Framework to Study Interactions of Epidemics and the Economy	5
Willingness to Pay per QALY: A Systematic Review of Demand-Side Valuations with a Focus on Age and Disease Severity	5
Cost-Utility Analysis of TAVI Versus Surgery in Low-Risk Patients with Severe Aortic Stenosis in the UK	5
Beyond the Diagnosis: Valuing Genome-Wide Sequencing for Rare Disease Diagnosis Using Contingent Valuation	4
The Increasing Value of Environmental Sustainability Assessments in Healthcare Policy and Technology Evaluation	4
How Does the New Australian EQ-5D-5L Value Set Impact Utility Scores? Analysis of Data from the Australian Orthopaedic Association National Joint Replacement Registry	4
myCOPD App for Managing Chronic Obstructive Pulmonary Disease: A NICE Medical Technology Guidance for a Digital Health Technology	4
The Short Form 6 Dimensions (SF-6D): Development and Evolution	4
Evolving Evidence-Based Value Assessment of One-Time Therapies: Tisagenlecleucel as a Case Study	4
Predicting Health Utilities Using Health Administrative Data: Leveraging Survey-linked Health Administrative Data from Ontario, Canada	4
Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study	4
Modelling Informal Carers’ Health-Related Quality of Life: Challenges for Economic Evaluation	4
Cost Effectiveness of Deep Brain Stimulation for Parkinson’s Disease: A Systematic Review	4
Informing Structural Assumptions for Three State Oncology Cost-Effectiveness Models through Model Efficiency and Fit	4
Opportunities for CMS to Further Specify and Broaden Its Approach to Assessing Unmet Medical Need in the Context of the Medicare Drug Price Negotiation Program	4
Agreement in Qualitative and Quantitative Assessments of Disease Severity: Evidence from Pharmaceutical Reimbursement in Sweden	4
Alternative Payment Models for Innovative Medicines: A Framework for Effective Implementation	4
UroLift for Treating Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance Update	3
Comment on: “10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?”	3
Estimating Transition Probabilities for Modeling Major Depression in Adolescents by Sex and Race or Ethnicity Combinations in the USA	3
The Economic Impact of Community Paramedics Within Emergency Medical Services: A Systematic Review	3
Value is Gendered: The Need for Sex and Gender Considerations in Health Economic Evaluations	3
Economic Evaluation of a Tumour-Agnostic Therapy: Dutch Economic Value of Larotrectinib in TRK Fusion-Positive Cancers	3
Should the Spanish National Health System Invest in Psychotherapy for Depression? A Microsimulation Cost-Utility Study to Estimate the Economically Justifiable Price of Cognitive Behavioral Therapy Ve	3
Methods and Practical Considerations for Conducting Budget Impact Analysis for Non-Pharmaceutical Interventions	3
The Gift of Time, How Do I Want to Spend It? Exploring Preferences for Time Allocation Among Women with and without a Breast Cancer Diagnosis	3
The Cost-Effectiveness of Initiating Patients on Home Dialysis Compared with In-Centre Haemodialysis	3
Cost of Carbon in the Total Cost of a Healthcare Procedure: Example of Micro-Costing Study in a French Setting	3
Acknowledgement to Referees	3
The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022	3
The Cost Effectiveness of Elective Surgical Procedures with Longer NHS Waiting Lists: A Targeted Review	3
Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women	3
Is the Use of Unanchored Matching-Adjusted Indirect Comparison Always Superior to Naïve Indirect Comparison on Survival Outcomes? A Simulation Study	3
Are Drug Novelty Characteristics Associated With Greater Health Benefits?	3
An Investigation into the Relationship Between Choice of Model Structure and How to Adjust for Subsequent Therapies Using a Case Study in Oncology	3
A Systematic Review of Microsimulation Models in Cardiometabolic Disease: Model Calibration and Validation	3
Cost Effectiveness of Adding Fenfluramine to Standard of Care for Patients with Dravet Syndrome in Sweden	3
The Cost-Effectiveness of Adjunctive Lifestyle Interventions for the Management of Cancer: A Systematic Review	3
Economic Evaluation of COVID-19 Immunization Strategies: A Systematic Review and Narrative Synthesis	3
Real-World Health and Economic Effects of a Large-Scale Outpatient Screening and Continuing Care Programme for Early Detection and Care of Microvascular Complications in Patients with Type 2 Diabetes	3
Health Interventions May Have Divergent Impacts on Health and Economic Equity: A Case Study of the Community-Based Hypertension Improvement Project in Ghana	3
Use of Health Technology Assessment for the Continued Funding of Health Technologies: The Case of Immunoglobulins for the Management of Multifocal Motor Neuropathy	2
The Italian Assessment System for Innovative Medicines: An 8-Year Retrospective Analysis of Outcomes, Criteria, Timelines and Funding Dynamics	2
Comment on: “Comparison of Caregiver and General Population Preferences for Dependency‑Related Health States”	2
Challenges in the Evaluation of Emerging Highly Specialised Technologies: Is There a Role for Living HTA?	2
Towards a Multi-sectoral Approach to Population Health: A Scoping Review of Cross-sectoral Evaluations of Health Interventions	2
Estimation of ‘spectrum value’: A discrete choice experiment to investigate the willingness-to-pay for narrow-spectrum based on other antimicrobial characteristics	2
Determining What Represents Value in the Treatment of Refractory or Unexplained Chronic Cough from the Perspective of Key Stakeholders in Spain Using Multi-Criteria Decision Analysis	2
Healthcare Costs and Carbon Emissions of Stage III Melanoma Surveillance Imaging	2
Compulsory Licensing as an Instrument to Tackle High Medicine Prices: A Realist Review of Industrial and Health Consequences	2
The False Economy of Seeking to Eliminate Delayed Transfers of Care: Some Lessons from Queueing Theory	2

Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government	2
Determinants of COVID-19 Vaccine Rollouts and Their Effects on Health Outcomes	2
A Systematic Review of Modelling Approaches in Economic Evaluations of Treatments for Inherited Bleeding Disorders	2
Treatment Preferences of Adolescents and Young Adults with Depressive Symptoms: A Discrete Choice Experiment	2
Acknowledgement to Referees	2
The Hidden Toll of Psychological Distress in Australian Adults and Its Impact on Health-Related Quality of Life Measured as Health State Utilities	2
The Cost Effectiveness of Genomic Medicine in Cancer Control: A Systematic Literature Review	2
Antimicrobial Resistance (AMR) Development Map: A Conceptual Map and a Tool to Support Economic Evaluation of AMR Interventions	2
Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis	2
The Inflation Reduction Act: Hope for Prescription Drug Prices in the USA	2
A Multi-dimensional Framework of Valued Output for Primary Care in England	2
Rationing in an Era of Multiple Tight Constraints: Is Cost-Utility Analysis Still Fit for Purpose?	2
Measurement of Health-Related Quality of Life from Conception to Postpartum Using the EQ-5D-5L Among a National Sample of US Pregnant and Postpartum Adults	2
What Interventions are Cost Effective in Reducing Violence Against Women? A Scoping Review	2
Data-Related and Methodological Challenges in Assessing the Cost-Effectiveness of Traditional and Genomic Newborn Screening Programs	2
Cost of Low-Value Imaging Worldwide: A Systematic Review	2
Health Inequalities: To What Extent are Decision-Makers and Economic Evaluations on the Same Page? An English Case Study	2
GaitSmart Rehabilitation Exercise Programme for Gait and Mobility Issues: A NICE Medical Technologies Guidance	2
A Systematic Review of Kidney Transplantation Decision Modelling Studies	2
Do the Poor Gain More? The Impact of Secondary-Care Expenditure on Health Inequality	2
Adding a Gene Expression Profile Test to Aid Differential Diagnosis and Treatment in Aggressive Large B-Cell Lymphoma: An Early Exploratory Economic Evaluation	2
The Impact of the Approach to Accounting for Age and Sex in Economic Models on Predicted Quality-Adjusted Life-Years	2
Policy Levers for First-Contact Healthcare Provider Choice: A Discrete Choice Experiment in Shanghai’s Hierarchical Medical System	2
Australian Preferences for Prenatal Screening: A Discrete Choice Experiment Comparing Metropolitan and Rural/Regional Areas	2
Willingness to Pay for One Additional Quality Adjusted Life Year: A Population Based Survey from China	2
Different Frameworks, Similar Results? Head-to-Head Comparison of the Generic Preference-Based Health-Outcome Measures CS-Base and EQ-5D-5L	2
A Contingent Valuation Study for Use in Valuing Public Goods with Health Externalities: The Case of Street Pianos	2
Cost-Effectiveness Analysis of Stockholm 3 Testing Compared to PSA as the Primary Blood Test in the Prostate Cancer Diagnostic Pathway: A Decision Tree Approach	2
Preferences of Women for Maternal Health Services in Sidama Region, Ethiopia: Discrete Choice Experiment	2
Correction: Exploring the Integration of Environmental Impacts in the Cost Analysis of the Pilot MEL-SELF Trial of Patient-Led Melanoma Surveillance	2
The Economic Cost of Obesity: A Cost-of-Illness Study in Greece	2
Methods for Economic Evaluations of Novel Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review	2
Budget Impact Analysis of the FreeStyle Libre Flash Continuous Glucose Monitoring System® in Patients with Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus with Multiple Daily Insulin Injections	2